One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Specimen Validity Testing Market

[ 英語タイトル ] Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023


Product Code : MNMHC00109800
Survey : MarketsandMarkets
Publish On : April, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

Global specimen validity testing market is projected to grow at 6.3% during the forecast period”

The specimen validity testing market is expected to reach USD 1.49 billion by 2023 from USD 1.10 billion in 2018, at a CAGR of 6.3%. Growth in the drug screening market and the increase in workplace drug testing are fueling the growth of the specimen validity testing market. On the other hand, market growth may be limited to a certain extent due to the emergence of alternative drug screening tests (such as oral fluid drug screening test.)

“Specimen validity testing services are expected to grow at the highest CAGR during the forecast period”
The specimen validity testing market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period; growth in this segment is attributed to the growing implementation of workplace drug testing in several countries, increasing number of drug screening tests, and the growing number of drug screening laboratories across the globe.

“By type, laboratory testing is expected to dominate the market during the forecast period”
The specimen validity testing market is segmented into laboratory testing and rapid/POC testing. The laboratory testing segment is expected to dominate the market during the forecast period. The accuracy of test results and cost-effectiveness of laboratory testing are other key factors driving the demand for this segment.
“Asia Pacific to witness high growth during the forecast period”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. The high growth in the APAC regional segment is attributed to the developing healthcare infrastructure, rising adoption of stringent regulatory guidelines for drug testing, increase in the number of illicit drug users, and strategic expansion of key market players in the region.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 24%; Tier 2 - 32%; Tier 3 - 44%.
• By Designation: C-level- 26%; D-level- 30%; others--44%.
• By Region: North America-48%; Europe-37%; Asia Pacific-10%; RoW-5%.
List of companies profiled in the report
• Alere (Subsidiary of Abbott Laboratories) (US)
• Thermo Fisher (US)
• Scitek (US)
• LabCorp (US)
• Quest Diagnostics (US)
• Alfa Scientific Designs (US)
• American Bio Medica Corporation (US)
• Express Diagnostics (US)
• ACM Global Laboratories (US)
• Clinical Reference Laboratory (CRL)
• Premier Biotech (US)

Research Coverage:
The report provides an overview of the specimen validity testing market. It aims at estimating the market size and growth potential of this market across different segments such as product and service, type, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in the specimen validity testing market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
 

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 LIMITATION 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH DATA 16
2.2 SECONDARY DATA 17
2.2.1 SECONDARY SOURCES 17
2.3 PRIMARY DATA 18
2.3.1 PRIMARY SOURCES 18
2.3.2 KEY INDUSTRY INSIGHTS 19
2.4 MARKET ESTIMATION 20
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.6 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 SPECIMEN VALIDITY TESTING MARKET OVERVIEW 28
4.2 SPECIMEN VALIDITY TESTING MARKET, BY TYPE (2018 VS. 2023) 28
4.3 SPECIMEN VALIDITY TESTING PRODUCTS MARKET, BY TYPE (2018 VS. 2023) 29
4.4 GEOGRAPHIC ANALYSIS: EUROPEAN SPECIMEN VALIDITY TESTING MARKET,
BY END USER AND REGION (2018) 30
4.5 GEOGRAPHIC SNAPSHOT: SPECIMEN VALIDITY TESTING MARKET (2018–2023) 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Growth in the drug screening market 33
5.2.1.2 Increase in workplace drug testing 33
5.2.2 RESTRAINTS 34
5.2.2.1 Emergence of alternative drug screening tests 34
5.2.3 MARKET OPPORTUNITIES 34
5.2.3.1 Rapid/Point-of-care specimen validity testing 34
5.2.4 MARKET TRENDS 35
5.2.4.1 Market consolidation 35
5.2.4.2 Regulatory approvals for rapid testing products 35
6 SPECIMEN VALIDITY TESTING MARKET, BY PRODUCT & SERVICE 36
6.1 INTRODUCTION 37
6.2 PRODUCTS 38
6.2.1 REAGENTS, CALIBRATORS, AND CONTROLS 39
6.2.2 ASSAY KITS 40
6.2.3 DISPOSABLES 41
6.3 SERVICES 43
7 SPECIMEN VALIDITY TESTING MARKET, BY TYPE 45
7.1 INTRODUCTION 46
7.2 LABORATORY TESTING 47
7.3 RAPID/POC TESTING 49
8 SPECIMEN VALIDITY TESTING MARKET, BY END USER 51
8.1 INTRODUCTION 52
8.2 WORKPLACES 53
8.3 DRUG SCREENING LABORATORIES 54
8.4 CRIMINAL JUSTICE AND LAW ENFORCEMENT AGENCIES 56
8.5 PAIN MANAGEMENT CENTERS 58
8.6 DRUG REHABILITATION CENTERS 59
8.7 OTHER END USERS 61
9 SPECIMEN VALIDITY TESTING MARKET, BY REGION 63
9.1 INTRODUCTION 64
9.2 NORTH AMERICA 66
9.2.1 US 68
9.2.2 CANADA 70
9.3 EUROPE 73
9.3.1 GERMANY 76
9.3.2 FRANCE 77
9.3.3 UK 79
9.3.4 REST OF EUROPE (ROE) 81
9.4 ASIA PACIFIC 84
9.5 REST OF THE WORLD (ROW) 88

10 COMPETITIVE LANDSCAPE 92
10.1 INTRODUCTION 92
10.2 MARKET RANKING ANALYSIS, BY KEY PLAYER 93
10.3 COMPETITIVE SCENARIO 94
10.3.1 PRODUCT LAUNCHES AND APPROVALS 94
10.3.2 ACQUISITIONS 95
10.3.3 PARTNERSHIP, AGREEMENTS, AND COLLABORATION 95
10.3.4 EXPANSIONS 95
11 COMPANY PROFILES 96
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ALERE (SUBSIDIARY OF ABBOTT LABORATORIES) 96
11.2 THERMO FISHER SCIENTIFIC 98
11.3 LABCORP 100
11.4 QUEST DIAGNOSTICS 102
11.5 AMERICAN BIO MEDICA CORPORATION (ABMC) 104
11.6 SCITECK 106
11.7 PREMIER BIOTECH 107
11.8 ALFA SCIENTIFIC DESIGNS 108
11.9 ACM GLOBAL LABORATORIES 110
11.10 EXPRESS DIAGNOSTIC INTERNATIONAL 111
11.11 CLINICAL REFERENCE LABORATORY 112

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 113
12.1 INSIGHTS FROM INDUSTRY EXPERTS 113
12.2 DISCUSSION GUIDE 114
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 117
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 119
12.5 AVAILABLE CUSTOMIZATIONS 120
12.6 RELATED REPORTS 120
12.7 AUTHOR DETAILS 121
 

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+